Leila Alland
Directeur/Membre du Conseil chez ABEONA THERAPEUTICS INC.
Fortune : 446 468 $ au 31/05/2024
Profil
Leila Alland is an Independent Director at Abeona Therapeutics, Inc., a Director at Jubilant Therapeutics, Inc., and a Non-Executive Director at Radiopharm Theranostics Ltd.
She previously worked as a Director at Cytovia Therapeutics, Inc., Chief Medical Officer at Affimed NV, Vice President & Head-Oncology at AstraZeneca LP, and Chief Medical Officer at Tarveda Therapeutics, Inc. She also held the position of Assistant Professor-Pediatrics at Albert Einstein College of Medicine, Inc. and Chief Medical Officer at PMV Pharmaceuticals, Inc. Alland received her undergraduate degree from the University of Pennsylvania and her doctorate from New York University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/05/2024 | 82 857 ( 0,20% ) | 362 914 $ | 31/05/2024 | |
| 15/09/2023 | 45 909 ( 0,09% ) | 83 554 $ | 31/05/2024 |
Postes actifs de Leila Alland
| Sociétés | Poste | Début |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Directeur/Membre du Conseil | 19/04/2021 |
| RADIOPHARM THERANOSTICS LIMITED | Directeur/Membre du Conseil | 06/06/2022 |
Jubilant Therapeutics, Inc.
 Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | Directeur/Membre du Conseil | 16/08/2021 |
Anciens postes connus de Leila Alland
| Sociétés | Poste | Fin |
|---|---|---|
| AFFIMED N.V. | Directeur Technique/Scientifique/R&D | 30/11/2019 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Directeur Technique/Scientifique/R&D | 01/03/2018 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Corporate Officer/Principal | 01/12/2015 |
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | 01/06/2000 |
| PMV PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Leila Alland
| New York University School of Medicine | Doctorate Degree |
| University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AFFIMED N.V. | Health Technology |
| PMV PHARMACEUTICALS, INC. | Commercial Services |
| ABEONA THERAPEUTICS INC. | Health Technology |
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Entreprise privées | 4 |
|---|---|
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
Jubilant Therapeutics, Inc.
Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | Health Technology |
